Hookipa Pharma Stock Investor Sentiment

HOOK Stock  USD 0.71  0.02  2.74%   
About 56% of all Hookipa Pharma's institutional investors are looking to take a long position. The analysis of the overall investor sentiment regarding Hookipa Pharma suggests that some traders are interested. Hookipa Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in Hookipa Pharma. The current market sentiment, together with Hookipa Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Hookipa Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Hookipa Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Hookipa daily returns and investor perception about the current price of Hookipa Pharma as well as its diversification or hedging effects on your existing portfolios.
  

Hookipa Pharma Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Hookipa Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at www.macroaxis.com         
Disposition of 11366 shares by Matushansky Igor of Hookipa Pharma at 0.1 subject to Rule 16b-3
Macroaxis News
few days ago at www.macroaxis.com         
Acquisition by Seghezzi Graziano of 9600 shares of Hookipa Pharma at 16.61 subject to Rule 16b-3
Macroaxis News
few days ago at globenewswire.com         
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635
Macroaxis News: globenewswire.com
few days ago at finance.yahoo.com         
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635
Yahoo News
six days ago at benzinga.com         
Acquisition by Roman Necina of 367300 shares of Hookipa Pharma at 0.76 subject to Rule 16b-3
benzinga news
over a week ago at news.google.com         
Hookipa Pharma receives PRIME designation for HB-200 program - TipRanks.com - TipRanks
Google News at Macroaxis
over a week ago at finance.yahoo.com         
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
Yahoo News
over two weeks ago at news.google.com         
Short Interest in Hookipa Pharma Inc Rises By 11.3 percent - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
Insider Trading
Google News at Macroaxis
over three weeks ago at news.google.com         
Q1 2024 EPS Estimates for Hookipa Pharma Inc Raised by Leerink Partnrs - Defense World
Google News at Macroaxis
over three weeks ago at news.google.com         
Hookipa Pharma Receives Buy Rating from HC Wainwright - Defense World
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
Time To Worry Analysts Just Downgraded Their HOOKIPA Pharma Inc. Outlook
Yahoo News
over three weeks ago at simplywall.st         
Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. Revenue Forecasts
Simply Wall St News at Macroaxis
over a month ago at globenewswire.com         
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highl...
Macroaxis News: globenewswire.com
over a month ago at investorplace.com         
HOOK Stock Earnings HOOKIPA Pharma Misses EPS, Beats Revenue for Q4 2023
sbwire news
Far too much social signal, news, headlines, and media speculation about Hookipa Pharma that are available to investors today. That information is available publicly through Hookipa media outlets and privately through word of mouth or via Hookipa internal channels. However, regardless of the origin, that massive amount of Hookipa data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hookipa Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hookipa Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hookipa Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hookipa Pharma alpha.

Hookipa Pharma Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Hooked Protocol Price Tops 0.97 on Major Exchanges
02/21/2024
2
Hookipa Pharma exotic insider transaction detected
02/23/2024
3
Hooked Protocol Achieves Self Reported Market Capitalization of 147.31 Million
02/27/2024
4
Absci Corporation Surges 10.0 percent Is This an Indication of Further Gains
03/01/2024
5
Hooked Protocol Self Reported Market Capitalization Reaches 183.27 Million
03/08/2024
6
What Is The Ownership Structure Like For HOOKIPA Pharma Inc. - Yahoo Movies UK
03/18/2024
7
Q1 2024 EPS Estimates for Hookipa Pharma Inc Raised by Leerink Partnrs - Defense World
03/27/2024
8
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
04/10/2024
9
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635
04/16/2024
10
Acquisition by Seghezzi Graziano of 9600 shares of Hookipa Pharma at 16.61 subject to Rule 16b-3
04/18/2024
11
Disposition of 11366 shares by Matushansky Igor of Hookipa Pharma at 0.1 subject to Rule 16b-3
04/19/2024
When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:
Check out Hookipa Pharma Hype Analysis, Hookipa Pharma Correlation and Hookipa Pharma Performance.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Hookipa Stock analysis

When running Hookipa Pharma's price analysis, check to measure Hookipa Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hookipa Pharma is operating at the current time. Most of Hookipa Pharma's value examination focuses on studying past and present price action to predict the probability of Hookipa Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hookipa Pharma's price. Additionally, you may evaluate how the addition of Hookipa Pharma to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Hookipa Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.86)
Revenue Per Share
0.213
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.32)
Return On Equity
(0.85)
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.